Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Greenbaum

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Nature|May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Discovery|February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule ReactivatorAnna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Nature Communications|December 10, 2020
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Nature|May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Discovery|February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule ReactivatorAnna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Nature Communications|December 10, 2020
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
Pageof 12